The functional significance of this axis was further confirmed in vivo, where OLFML2A knockdown suppressed tumor growth in both subcutaneous and intracranial glioma xenograft models by impairing Wnt/β-catenin-dependent proliferatio (14). Here, OLFML2A is linked to central nervous system cancer.